Healthcare data analytics company will use funds to expand product offerings, invest in sales, marketing and customer success
NASHVILLE, Tenn. (July 10, 2019) — Stratasan, LLC (“Stratasan” or the “Company”), a Nashville-based healthcare data analytics software provider, is pleased to announce it has completed a $26 million investment round led by Fulcrum Equity Partners with participation from Frist Cressey Ventures, Blue Heron Capital, Bridge Bank and Company management. Stratasan will use this capital to further expand its product offerings as well as invest in its sales, marketing, and customer success teams.
“We are profoundly grateful for the opportunity to partner with three operationally focused growth equity firms to begin the next chapter in our journey,” said Jason Moore, Stratasan’s co-founder and CEO. “We’ve built a customer-first culture, and our entire team is looking forward to providing increased value to our current and future customers through this new investment. As we look to the future, I want to be sure to also thank our current investors and the TNInvestCo program, as they were pivotal in helping us get to where we are today.”